Retatrutide is a newly discovered compound that shows promise as a treatment for type 2 diabetes. It functions as a activator of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://amberiuwk206086.mdkblog.com/45161023/dulaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes